GGrantIndex
Sort

8,912 grants matching “sars cov 2”

Inflammation, Macrophage Differentiation, and Cancer

$630,814
Zheng-Gang Liu · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Investigator Development

$630,801
Hakeem O Lawal · Delaware State University · U54 · FY2025 · MD

Brain pathophysiology in SARS-CoV-2 disease

$630,502
Kathryn L Sandberg · Georgetown University · R01 · FY2022 · NS

Development of simpler immunotheraputics

$630,497
Arya Biragyn · National Institute On Aging · ZIA · FY2021 · AG

Understanding the Risk of Bat Coronavirus Emergence

$630,445
Peter Daszak · Ecohealth Alliance, Inc. · R01 · FY2015 · AI

TOP3B as host factor and drug target

$630,435
Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Monocyte-derived alveolar macrophage drives inflammatory response to lung ozone exposure

$630,363
Robert Matthew Tighe · Duke University · R01 · FY2022 · ES

K-VAC: Kentucky Vaccinating Appalachian Communities

$629,515
Marc T Kiviniemi · University Of Kentucky · R01 · FY2023 · MD

Humoral Immune Mechanisms of Acute and Chronic Neurologic Sequelae of COVID-19

$629,459
Michael R Wilson · University Of California, San Francisco · R01 · FY2023 · NS

Developing a dynamic modeling framework for surveillance, prediction, and real-time resource allocation to reduce health disparities during Covid-19 and future pandemics

$629,335
Lior Rennert · Clemson University · R01 · FY2024 · LM

T cell analysis of COVID infection and vaccination

$629,324
Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

VALE+TU SALUD: CORNER-BASED RANDOMIZED TRIAL TO TEST A LATINO DAY LABORER PROGRAM ADAPTED TO PREVENT COVID 19

$629,270
Maria Eugenia Fernandez-Esquer · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · MD

Macaque Model and Gene Expression Profiling of SARS

$628,995
Michael G Katze · University Of Washington · R01 · FY2009 · HL

Heat Therapy for the treatment of post-acute COVID-19 syndrome

$628,848
Gwenael Layec · University Of Nebraska Omaha · R01 · FY2025 · AG

VALE+TU SALUD: CORNER-BASED RANDOMIZED TRIAL TO TEST A LATINO DAY LABORER PROGRAM ADAPTED TO PREVENT COVID 19

$628,766
Maria Eugenia Fernandez-Esquer · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · MD

Community Developed Technology-Based Messaging to Increase SARS-CoV-2 Vaccine Uptake Among People Who Inject Drugs

$628,668
Ian David Aronson · New York University · R01 · FY2023 · DA

Insights into Sickle Cell Trait and Sickle Cell Disease

$628,447
Vence L Bonham · National Human Genome Research Institute · ZIA · FY2023 · HG

Investigator Development

$628,377
Brian Richard McNaughton · Delaware State University · U54 · FY2023 · MD

Clonal Dynamics of the antibody response

$628,260
Gabriel D Victora · Rockefeller University · R01 · FY2022 · AI

Clonal Dynamics of the antibody response

$628,260
Gabriel D Victora · Rockefeller University · R01 · FY2023 · AI

Clonal Dynamics of the antibody response

$628,257
Gabriel D Victora · Rockefeller University · R01 · FY2024 · AI

Host factors contributing to susceptibility to COVID-19 disease

$628,084
Helen Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Mechanisms underlying delayed neurocognitive dysfunction in long-covid

$627,797
Paul E Schulz · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · AG

Longitudinal analysis to determine persistence of T cell responses induced by SARS-CoV-2 vaccination, natural infection with SARS-CoV-2, and human common cold coronaviruses

$627,760
Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2022 · AI

A Novel Model for the Study of Lung Pathogenesis of SARS

$627,463
Linqi Zhang · Aaron Diamond Aids Research Center · R01 · FY2007 · HL